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Early diagnosis of infective endocarditis (IE) is based on the yielding
of blood cultures and echocardiographic findings. However, they
have limitations and sometimes the diagnosis is inconclusive,
particularly in patients with prosthetic valves (PVs) and implantable
cardiac electronic devices (ICEDs). The primary aim of this study
was to evaluate the diagnostic accuracy of 18F-FDG PET/CT in
patients with suspected IE and ICED infection. Methods: A pro-
spective study with 80 consecutive patients with suspected IE
and ICED infection (65 men and 15 women with a mean age of 68 ±
13 y) between June 2013 and May 2015 was performed in our hos-
pital. The inclusion criteria were clinically suspected IE and ICED
infection at the following locations: native valve (NV) (n 5 21), PV
(n 5 29), or ICED (n5 30) (automatic implantable defibrillator [n5 11]
or pacemaker [n 5 19]). Whole-body 18F-FDG PET/CT with a myo-
cardial uptake suppression protocol with unfractionated heparin
was performed in all patients. The final diagnosis of infection was
established by the IE Study Group according to the clinical, echo-
cardiographic, and microbiologic findings. Results: A final diagno-
sis of infection was confirmed in 31 patients: NV (n5 6), PV (n5 12),
and ICED (n 5 13). Sensitivity, specificity, positive predictive value,
and negative predictive value for 18F-FDG PET/CT were 82%, 96%,
94%, and 87%, respectively. 18F-FDG PET/CT was false-negative in
all cases with infected NV. 18F-FDG PET/CT was able to reclassify
63 of 70 (90%) patients initially classified as possible IE by modified
Duke criteria. In 18 of 70 cases, 18F-FDG PET/CT changed possible
to definite IE (26%) and in 45 of 70 cases changed possible to
rejected IE (64%). Additionally, 18F-FDG PET/CT identified 8 cases
of septic embolism and 3 of colorectal cancer in patients with a final
diagnosis of IE. Conclusion: 18F-FDG PET/CT proved to be a useful
diagnostic tool in suspected IE and ICED infection and should be
included in the diagnostic algorithm for early diagnosis. 18F-FDG
PET/CT is not useful in the diagnosis of IE in NV but should be also
considered in the initial assessment of this complex scenario to rule
out extracardiac complications and possible neoplasms.
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Infective endocarditis (IE) entails a high risk of mortality and
severe complications (1). Moreover, early diagnosis and detection
of possible complications of IE remain a challenge in clinical
practice (2). To improve outcomes, the diagnosis and management
of IE should be shared by well-coordinated diverse specialists
working together as a multidisciplinary team (3). Blood cultures
and echocardiographic findings are still the cornerstone in the
suspicion and initial diagnosis of IE, which will be confirmed or
rejected according to modified Duke criteria (4). However, the
diagnostic yielding of current criteria is not optimal, with a large
percentage of cases remaining as possible IE at the end of the
episode (5). This is partially due to difficulties in the interpretation
of echocardiographic findings in patients with intracardiac devices
such as prosthetic valves (PVs) and implantable cardiac electronic
devices (ICEDs) (6).
Early detection and drainage, if required, of embolic compli-
cations as well as enlarging the length of antibiotic therapy are
crucial for improving immediate and late outcomes of IE, including
relapses (7,8). Additionally, some microorganisms frequently
causing IE such as bovis group streptococci are linked to under-
lying neoplasms (9). The detection of a neoplasm in the context of
IE might significantly affect other therapeutic decisions and their
timing, such as the parameters of cardiac surgery. Therefore, pros-
pects in the approach of IE rely on available and easy-to-perform
tests that provide data on different issues promptly, so that early
measures could be applied.
18F-FDG PET/CT is an emerging image technique that has
proven useful in the diagnosis of a variety of infectious diseases
(10,11). Its utility is due to the ability of 18F-FDG to actively in-
corporate into activated leukocytes, macrophages, and CD4-positive
T cells present at the sites of infection (12,13). Recent studies have
reported encouraging results for 18F-FDG PET/CT in the diagnosis
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of IE and ICED infection (14–16) as well as in the detection of
extracardiac complications (17,18). In the most recent guidelines
(2015) of the European Society of Cardiology, 18F-FDG PET/CT
has been included as a major criterion of PV endocarditis (PVE)
diagnosis and also in the diagnostic algorithm for the detection of
embolic events for both native valve IE (NVE) and PVE (7).
The primary aim of this study was to evaluate the diagnostic
accuracy of 18F-FDG PET/CT in patients with suspected NVE, PVE,
ICED IE, and other ICED-associated infections. The secondary aims
were to evaluate the interobserver agreement and the added value of
quantification using SUV in the diagnosis of infection.
MATERIALS AND METHODS
Patients and Design
Retrospective analysis of prospectively collected data from 80
consecutive patients (65 men and 15 women with a mean age of 68 6
13 y) with suspected IE and ICED infection who were seen in our
hospital from June 2013 to May 2015 was performed. Since 1979, all
patients with IE attended at the Hospital Clinic of Barcelona have
been managed by a multidisciplinary group that met for weekly
meetings (19). We included patients with a clear suggestion of native
or PV IE and ICED IE or infection, at least accomplishing Duke
modified criteria to be initially considered as possible cases. After
the diagnostic process, including 18F-FDG PET/CT and other tests,
cases were classified according to modified Duke criteria (4) as
rejected, definite, or possible. In the case of ICED, and due to the
common management in all cases (removal of the device), we used
the definitions provided by the last British Society for Antimicrobial
Chemotherapy guidelines (20) for those cases not presenting vegeta-
tions (i.e., pocket infection and ICED lead infection). The final diag-
nosis of infection was established by the multidisciplinary working group
according to the clinical, echocardiographic, and microbiologic findings.
18F-FDG PET/CT results were communicated to referring clinicians
shortly after the test was done. Thus, 18F-FDG PET/CT was used as a
diagnostic tool also, being a major criterion in the case of PVE, as
recognized by the last European Society of Cardiology guidelines (7).
In the case of ICED, 18F-FDG PET/CT was used in the cases in which
the suspicion was high but none of the classic findings of ICED-associated
infection was present (local inflammation of the generator pocket, bac-
teremia, or vegetations). Definitions of variables related to IE were col-
lected in the clinical sheet of all patients. The following suspected
TABLE 1
Baseline Characteristics of Study Group Patients
Characteristic All cases (n 5 80)
Definite IE/ICED
infection (n 5 10)
Possible IE/ICED
infection (n 5 70) P
Mean age ± SD (y) 68 ± 13 71 ± 14 68 ± 13 0.50
Sex (n)
Female 15 (19%) 2 (20%) 13 (19%) 0.94
Male 65 (81%) 8 (80%) 57 (81%) 0.94
Hypertension (n) 43 (54%) 5 (50%) 38 (54%) 0.81
Diabetes (n) 28 (35%) 3 (30%) 25 (36%) 0.71
Cardiac valve prosthesis* 33 3 30 0.44
Aortic 20 2 18 0.68
Biologic 12 0 12 0.34
Mechanical 8 2 6 0.22
Mitral 13 1 12 0.57
Biologic 4 0 4 0.90
Mechanical 9 1 8 0.92
Cardiac device* 36 3 33 0.31
Pacemaker 23 0 23 0.055
Defibrillator 13 3 10 0.19
Echocardiography (n)
Transthoracic 80 (100%) 10 (100%) 70 (100%) 1
Transesophageal 62 (77%) 9 (90%) 53 (76%) 0.32
Median time from
PV or cardiac device
implantation (mo)
47 (interquartile
range, 11–120)
54 (interquartile
range, 18–120)
41 (interquartile
range, 11–93)
0.12
,1 y (n) 25 (36%) 1 (10%) 24 (34%) 0.12
$1 y (n) 44 (64%) 9 (90%) 35 (50%) 0.01
Days of antibiotics
before PET/CT
15 (interquartile
range, 8–30)
20 (interquartile
range, 12–30)
13 (interquartile
range, 8–25)
0.004
*Number of PVs and cardiac devices do not match with number of patients because some had . 1 PV or simultaneous PV and cardiac
device.
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episodes were included NVE (n5 21), PVE (n5 29), and ICED IE or
ICED infection (n 5 30) (automatic implantable defibrillator [n 5
11] or pacemaker [n 5 19]). All the patients were under antibiotic
therapy. The baseline characteristics of the patients are shown in
Table 1. The exclusion criteria included severe hemodynamic insta-
bility and indications for emergent surgery. All patients surviving the
initial admission had at least a follow-up of 6 mo.
The institutional review board approved this study, and all subjects
signed a written informed consent form.
PET/CT
Whole-body scans were obtained using a hybrid PET/CT scanner
(Biograph mCT 64S; Siemens). A myocardial uptake suppression
protocol was followed with a fasting period for at least 12 h and
intravenous administration of 50 IU/kg of unfractionated heparin
15 min before the injection of 18F-FDG (4.0 MBq/kg). Blood glucose
levels were required to be less than 150 mg/dL during a period of
approximately 60 min before the administration of the 18F-FDG; dur-
ing acquisitions, patients were supine with their arms raised above the
head. Whole-body PET data were acquired in 3-dimensional mode
and for 3 min per bed position.
Image Interpretation
Images were interpreted separately by 2 independent observers
(2 nuclear medicine specialists trained on infection and 18F-FDG
PET/CT who were masked to the clinical results). Disagreements were
settled by consensus with a third nuclear medicine specialist. The cri-
teria for infection were visual and considered positive when focal or
heterogeneous increase in 18F-FDG activity related to the PV, NV, or
ICED was identified in the attenuation-corrected and -uncorrected im-
ages. A semiquantitative analysis was made using the SUVmax in the area
of suspected infection. The SUVmean was obtained in the blood pool (su-
perior cava vein) and in the liver to establish SUV ratios. The SUV ratio
was calculated by dividing the SUVmax of the area of interest by the blood-
pool SUVmean (SUVmax ratio 1) and the liver SUVmean (SUVmax ratio 2).
Myocardial uptake suppression was classified in 3 categories as
complete inhibition uptake (less or equal to liver uptake), partial inhibition
(focally above to liver), and noninhibition (diffusely superior to liver
uptake). Receiver-operating-characteristic curves with 2 different thresh-
olds regarding total optimization and sensitivity optimization for SUVmax
and SUVmax ratios have been obtained.
Statistical Analysis
The analyses were performed using SPSS (version 22.0; SPSS Inc.).
Sensitivity, specificity, positive predictive value, and negative predic-
tive value were calculated. Interagreement k was obtained. Receiver-
operating-characteristic curves and total and sensitivity optimization
thresholds were calculated. P values of less than 0.05 were considered
statistically significant. A Mann–Whitney U test for continuous vari-
ables and a Fisher exact test for nominal variables were used to assess
differences between groups with P values of less than 0.05 considered
statistically significant.
RESULTS
A final diagnosis of infection was established in 31 patients:
NVE (n5 6), PVE (n5 12) (biologic valve [n5 5] or mechanical
valve [n 5 7]), ICED IE (n 5 8), and ICED pocket or lead in-
fection (n 5 5) (automatic implantable defibrillator [n 5 5] or
pacemaker [n 5 8]) (Figs. 1 and 2A). Forty-seven patients were
rejected, and 2 patients remained as possible. In 28 of 31 episodes,
causative microbial agents were identified, with Staphylococcus
aureus (n 5 8) and coagulase-negative staphylococci (n 5 6) the
most frequently isolated (Table 2). Sensitivity, specificity, positive
predictive value, and negative predictive value for 18F-FDG PET/CT
were 82%, 96%, 94%, and 87%, respectively. When suspected NVE
was excluded from the analysis, these values changed to 96%, 94%,
93%, and 97%, respectively.
In our series, 18F-FDG PET/CT was able to reclassify 63 of 70
cases (90%) initially classified as possible IE by modified Duke
criteria. In 18 of 70 cases, 18F-FDG PET/CT changed possible to
definite IE (26%) and in 45 of 70 cases changed possible to re-
jected IE (64%) (Table 3). Additionally, 18F-FDG PET/CT iden-
tified 8 cases of septic embolism (26%) in patients with a final
diagnosis of IE (pulmonary, splenic, and vertebral in 4, 2, and 2
cases, respectively) (Fig. 2B) and 3 cases of colorectal cancer in
patients with IE caused by Streptococcus bovis (n 5 2) and En-
terococcus faecalis (n 5 1).
Among those patients with suspected IE or ICED infection
whose diagnosis was eventually rejected, 18F-FDG PET/CT find-
ings were pneumonia (n 5 4), hip septic arthritis (n 5 2), spon-
dylodiskitis (n 5 2), sternal osteomyelitis (n 5 1), vascular aortic
graft infection (n5 1), and lymphoma (n5 1). Interestingly, 18F-FDG
PET/CT detected the source of infection in 7 of 15 patients
(47%) with NV and rejected IE as a final diagnosis.
18F-FDG PET/CT retrieved 7 false-negative results in patients
with definite IE, including all 6 cases with NVE and 1 case of PVE.
FIGURE 1. Pocket generator and lead infection in patient with auto-
matic implantable defibrillator. Transverse (A) and sagittal (B) 18F-FDG
PET/CT images. Device was removed. Both generator and lead cul-
tures were positive for Staphylococcus aureus.
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There were no significant differences on the length of antibiotic
therapy before 18F-FDG PET/CT performance between false-negative
and true-positive results (P 5 0.87). On the contrary, there were
2 18F-FDG PET/CT false-positive cases with suggestion of early
PVE (1 and 8 mo after cardiac surgery, respectively).
The most valuable semiquantitative score to diagnose infection
was SUVmax (Table 4). However, we did not find any significant
improvement using semiquantitative scores in terms of sensitivity
and specificity compared with visual analysis. Myocardial uptake
inhibition was achieved in 75% of the patients (49 complete and
11 partial). Additionally, mean SUVmax in the group of patients
with a complete inhibition of the myocardium and in the non-
inhibited group were 3.7 6 1.3 and 12.3 6 6.1 (P , 0.01), re-
spectively (Fig. 3). The mean SUVmax in partially inhibited
patients was 5.9 6 1.4 (P 5 not significant).
There were 74 18F-FDG PET/CT concordant results of the 80
included cases corresponding to a 92% of agreement. The k-statistics
value to measure interrater agreement was 0.81 (P , 0.01).
DISCUSSION
Despite an accurate multidisciplinary approach, IE and ICED
infections remains still underdiagnosed. As a consequence, the
equivocal timing of empiric treatment instauration and consider-
ation for cardiac surgery leads to poor prognosis in a considerable
proportion of patients. The presence of PV and ICED consistently
decreases the sensitivity and specificity of echocardiography, to
about 20% for transthoracic echocardiography and around 90%
(in the hands of experienced operators) for transesophageal
echocardiography (6). Erba et al. (21) have demonstrated that
99mTc-HMPAO white blood cell–labeled scintigraphy is useful
to locate the source of infection in patients with sepsis of different
origins. However, this technique is time-consuming and its reso-
lution is low, even using SPECT/CT images.
The earliest studies with 18F-FDG PET/CT in IE showed low
sensitivities for detecting intracardiac infectious foci, which were
attributed to the high myocardium physiologic uptake. Inspired by
viability studies, several works have developed different strategies
to inhibit myocardial uptake. In most studies, 18F-FDG PET/CTwas
performed after a long fasting period (at least 12 h) and a previous
meal rich in fat and low in carbohydrates (14). In a series of 101
patients, Williams et al. showed that a high-fat, low-carbohydrate,
protein-permitted meal eaten 3–6 h before 18F-FDG injection was
useful, because the average SUVmax was significantly lower for the
high-fat, low-carbohydrate, protein-permitted meal group than for
FIGURE 2. (A) Transverse and coronal 18F-FDG PET/CT images show
infected prosthetic aortic valve. Culture after valve removal was posi-
tive for Propionibacterium acnes. (B) Fusion PET/CT images also dem-
onstrate septic spleen embolisms.
TABLE 2
Main Outcomes in Group of Patients with Final Diagnosis of
IE and ICED Infection
Characteristic n 5 31
Symptoms (n)
Fever* 24 (77)
Skin signs of infection 3 (10)
Peripheral symptoms 3 (10)
Heart failure 4 (13)
Septic shock 2 (6)
Echocardiographic findings (n)
Vegetations 11 (35)
Periannular complications 8 (26)
New valve regurgitation 3 (10)
No findings 9 (29)
Causal microorganisms (n)
Staphylococcus aureus 8 (26%)
CoNS 6 (19%)
VGS 4 (13%)
GNR 3 (10%)
Enterococcus faecalis 1 (3%)
Streptococcus bovis 2 (6%)
Other microorganisms 4 (13%)
Not identified 3 (10%)
Diagnostic microbiologic tests (n)
Blood cultures 19 (61%)
Valve or cardiac device cultures 9 (29%)
Cardiac surgery/percutaneus ICED extraction 18 (58%)
Mortality related to IE episode 2 (6%)
*Temperature . 37.3°C.
CoNS 5 coagulase-negative Staphylococcus; VGS 5 viridans
group streptococci; GNR 5 gram-negative rods.
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the fasting group (8.86 5.7 and 3.96 3.6, respectively) (22). In our
series, we found similar scores of mean SUVmax in the group of
patients with a complete inhibition of the myocardium using hepa-
rin of 3.7 6 1.3. However, we could only consider a complete
myocardial uptake inhibition in 49 patients (61%) and partial in-
hibition in 11 patients (14%), so it would be of interest to compare
both methods to define whether myocardial uptake suppression
could be improved. The most accurate procedure described in the
literature includes prolonged fasting with a low-carbohydrate diet
and heparin injection (23).
There is an increasing amount of studies from groups waging to
implement 18F-FDG PET/CT as an essential tool for IE and ICED
infection diagnosis (14–16). Saby et al. suggested that the sensi-
tivity of the modified Duke criteria to diagnose PVE can be
enhanced if 18F-FDG PET/CT results are incorporated into a com-
prehensive approach including clinical, microbiologic, and echo-
cardiographic parameters (14). Pizzi et al. found that the addition
of 18F-FDG PET/CT as a major Duke criterion at admission sig-
nificantly increased diagnostic sensitivity from 52% to 90.7%,
with only a minor decrease in specificity, mainly due to a signif-
icant reduction in the number of possible IE cases (from 54% to
5%) (24). However, these authors included initially rejected patients
by modified Duke criteria, probably making less cost-effective the
indication of 18F-FDG PET/CT in suspected IE. Our study did not
include initially rejected IE patients by modified Duke criteria
showing a high specificity in all the indications in which 18F-FDG
PET/CT was performed (including and excluding NV, specificities
were 96% and 94%, respectively). Moreover, 18F-FDG PET/CT
allowed reclassification of the 90% of our patients who were initially
classified as possible IE. Pizzi et al. also recommended the use of
hybrid electrocardiographic gating and contrast-enhanced PET/CT
but they did not find significant differences in sensitivity and spec-
ificity between contrast and non–contrast-enhanced PET/CT.
On the other hand, contrast-enhanced PET/CT represents an increase
in both complexity of the procedure and dosimetry (increase of
median effective radiation dose from 15.3 to 25.3 mSv) (24).
18F-FDG PET/CT may determine the surgical management of
patients with IE, and simultaneous ICED and PV, because of its high
TABLE 3
Classification According to Initial Diagnosis Criteria, 18F-FDG PET/CT Results, and Final Diagnosis Criteria
Classification Initial diagnosis criteria (n) 18F-FDG PET/CT results (n) Final diagnosis criteria (n)
PV (n 5 30)
Definite 3 (10) 13 (43)* 12 (40)
Possible 27 (90) 0 (0) 1 (3)
Rejected 0 (0) 17 (57)† 17 (57)
NV (n 5 21)
Definite 4 (19) 0 (0) 6 (29)
Possible 17 (81) 0 (0) 1 (5)
Rejected 0 (0) 21 (100)‡ 14 (66)
ICED (n 5 29)
Definite 3 (10) 13 (45) 13 (45)
Possible 26 (90) 0 (0) 0 (0)
Rejected 0 (0) 16 (55) 16 (55)
Total (n 5 80)
Definite 10 (12) 26 (32) 31 (39)
Possible 70 (88) 0 (0) 2 (5)
Rejected 0 (0) 54 (68) 47 (56)
*Two false-positive cases.
†One false-negative case.
‡Six false-negative cases.
Data in parentheses are percentages.
TABLE 4
Optimization of SUVmax and SUVmax Ratios Through
Receiver-Operating-Characteristic Curves to Establish Most
Appropriate Threshold to Diagnose IE/ICED Infection
Optimization Threshold Sensitivity (%) Specificity (%)
Total
SUVmax 3.485 91.3 (82.2–96.7) 93.7 (85.3–98.1)
SUV ratio 1* 2.388 87.0 (80.0–93.8) 91.7 (82.7–96.9)
SUV ratio 2† 1.373 91.3 (82.2–96.7) 81.2 (70.2–89.4)
Sensitivity
SUVmax 2.105 95.7 (88.0–99.1) 60.4 (48.1–71.8)
SUV ratio 1* 1.459 95.7 (88.0–99.1) 64.6 (52.3–75.5)
SUV ratio 2† 1.099 95.7 (88.0–99.1) 64.6 (52.3–75.5)
*SUVmax ratio 1 5 SUVmax/blood-pool SUVmean.
†SUVmax ratio 2 5 SUVmax/liver SUVmean.
Data in parentheses are 95% CIs.
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negative predictive value (97% when NVE are excluded), was helpful
in selecting which device should be removed. 18F-FDG PET/CT also
was able to detect the source of infection in 7 of 15 patients (47%)
with NV and rejected IE.
As it was pointed out by Chen et al., the myocardial uptake
observed in the immediate postoperative period may be more
likely related to persistent inflammatory changes rather than an
ongoing infection (25). In our series we only found 2 false-positive
cases, both suggestive of early PVE, in which 18F-FDG PET/CT was
performed 1 and 8 mo after surgery, respectively. However, we have
not found any false-positive case in the ICED group, even in the im-
planted devices for which it has been less than 1 y since implantation.
The presence of septic emboli is crucial for the correct manage-
ment of patients with IE and ICED infection. Failure to identify
metastatic infection complications may lead to early interruption of
therapy, thus potentially triggering relapse and an unfavorable
outcome. Infectious embolisms are not uncommon as they can
appear between 20% and 50% of patients and can be asymptom-
atic and difficult to recognize (7,17,18). We were able to identify
up to 8 cases of clinically unsuspected septic embolism situated
mainly in the lung and in the bone. On the other hand, 18F-FDG
PET/CT diagnosed 3 confirmed colorectal cancer cases linked
to IE caused by Streptococcus bovis and Enterococcus faecalis (9).
Sarrazin et al. studied the value of a semiquantitative 4 grade-
scale for 18F-FDG uptake, which failed to accurately discriminate
infection in patients with ICED (16). In our series, we used SUVmax
and 2 different SUV ratios with blood-pool SUVmean and the
liver SUVmean, concluding that SUVmax is the most appropriate
semiquantitative parameter, with a sensitivity and specificity both
superior to 90%. However, there was no additional value of using
SUVmax compared with visual analysis, so semiquantitative score
should not be recommended for daily clinical practice for diagno-
sis of infection in these patients.
This study has several limitations. First, because results of 18F-FDG
PET/CT were made available to clinicians immediately after the
test was performed, subsequent treatment of the patients including
decisions to perform surgery were influenced by the index test. Sec-
ond, a complete myocardial uptake inhibition was not achieved in all
patients, so our suggested preparation of prolonged fasting and hep-
arin must be combined with a low-carbohydrate diet (23).
CONCLUSION
18F-FDG PET/CT proved to be a useful
technique and should be included in the
algorithm flowchart for early diagnosis of
PVE, ICED IE, and ICED infection, reduc-
ing the rate of misdiagnosed patients.
Furthermore, 18F-FDG PET/CT can simul-
taneously diagnose systemic complications
such as septic emboli and unsuspected neo-
plasms, influencing substantially the clini-
cal management of the patients. However,
18F-FDG PET/CT was not useful in the di-
agnosis of NVE, although in this group of
patients 18F-FDG PET/CT does improve the
detection of the potential source of infec-
tion. In addition, the interobserver agree-
ment was excellent, and we did not find
any significant improvement of quantifica-
tion using SUV compared with visual anal-
ysis in diagnosis of infection in this series.
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